Icade (LTS:0K4O)
€ 23.55 0.6 (2.61%) Market Cap: 1.78 Bil Enterprise Value: 5.39 Bil PE Ratio: 0 PB Ratio: 0.40 GF Score: 53/100

Icade SA Corporate Call Transcript

Mar 14, 2023 / 09:00AM GMT
Release Date Price: €48.63 (+4.63%)
Operator

Hello, and welcome to today's Icade conference call. Please note that this conference is being recorded (Operator Instructions) I will now hand over to your host, Olivier Wigniolle, CEO; and Victoire Aubry, CFO, to begin today's call.

Olivier Wigniolle
Icade - MD & CEO

Thank you. So good morning, everyone. So I'm Olivier Wigniolle speaking, and I am with Victoire Aubry and also (inaudible). We have organized this call just to present the transaction that occurred yesterday because yesterday, we have signed an exclusivity agreement with Primonial in order to sell our stake in Icade Santé.

So as you could see, I am on Slide 2 of the presentation. Maybe to start with, and just to remind you some figures about our stake in healthcare real estate. In terms of value, in terms of NAV value at the end of last year, it represents a value of EUR 2.6 billion based on the NTA NAV, which [were it's] peak in 2 parts, EUR 2.3 billion for Icade Santé and EUR 0.3 billion for Icade Healthcare Europe, which is more the international portfolio. And just also to

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot